SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001206774-04-000346
Filing Date
2004-04-19
Accepted
2004-04-19 08:00:10
Documents
5
Effectiveness Date
2004-04-19

Document Format Files

Seq Description Document Type Size
1 d14465_def14a.htm DEFR14A 339226
3 GRAPHIC averywsig.jpg GRAPHIC 6130
4 GRAPHIC chart.jpg GRAPHIC 41845
5 GRAPHIC jbarriewig.jpg GRAPHIC 7310
6 GRAPHIC logo.jpg GRAPHIC 5644
  Complete submission text file 0001206774-04-000346.txt   402133
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 000-15006 | Film No.: 04739426
SIC: 2835 In Vitro & In Vivo Diagnostic Substances